Entry Point Capital, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Entry Point Capital, LLC
- $221 Million
- Q4 2024
A detailed history of Entry Point Capital, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 13,658 shares of AMPH stock, worth $383,243. This represents 0.23% of its overall portfolio holdings.
Number of Shares
13,658
Previous 9,310
46.7%
Holding current value
$383,243
Previous $451,000
12.42%
% of portfolio
0.23%
Previous 0.26%
Shares
4 transactions
Others Institutions Holding AMPH
# of Institutions
275Shares Held
35.2MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$167 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$76.2 Million0.0% of portfolio
-
Td Asset Management Inc1.84MShares$51.6 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$44.8 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$38.6 Million0.04% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.38B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...